XML 15 R4.htm IDEA: XBRL DOCUMENT v3.21.2
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Jul. 31, 2021
Aug. 01, 2020
Jul. 31, 2021
Aug. 01, 2020
Income Statement [Abstract]        
Total net revenue [1] $ 1,194,156 $ 883,510 $ 2,228,769 $ 1,435,202
Cost of sales, including certain buying, occupancy and warehousing expenses 691,765 618,311 1,290,188 1,141,697
Gross profit 502,391 265,199 938,581 293,505
Selling, general and administrative expenses 293,939 223,711 558,430 411,908
Impairment, restructuring and COVID-19 related charges 0 14,611 [1] 0 170,231 [1]
Depreciation and amortization expense 40,456 39,114 78,727 81,844
Operating income (loss) [1] 167,996 (12,237) 301,424 (370,478)
Interest expense, net 8,921 8,547 17,426 8,693
Other (income) expense, net (1,363) (1,554) (3,223) 1,429
Income (loss) before income taxes 160,438 (19,230) 287,221 (380,600)
Provision (benefit) for income taxes 38,927 (5,478) 70,244 (109,685)
Net income (loss) $ 121,511 $ (13,752) $ 216,977 $ (270,915)
Net income (loss) per basic share $ 0.73 $ (0.08) $ 1.29 $ (1.63)
Net income (loss) per diluted share $ 0.58 $ (0.08) $ 1.04 $ (1.63)
Weighted average common shares outstanding - basic 167,491 166,315 168,036 166,461
Weighted average common shares outstanding - diluted 208,933 166,315 208,400 166,461
[1]

The difference between Operating income (loss) and Income (loss) before income taxes includes the following items, which are not allocated to our reportable segments:
- For the 13 weeks ended July 31, 2021, interest expense, net of $8.9 million and other (income) expense, net of ($1.4) million. For the 26 weeks ended July 31, 2021, interest expense, net of $17.4 million and other (income) expense, net of ($3.2) million.
- For the 13 weeks ended August 1, 2020, interest expense, net of $8.5 million and other (income) expense, net of ($1.6) million. For the 26 weeks ended August 1, 2020, interest expense, net of $8.7 million and other (income) expense, net of $1.4  million.